These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
776 related items for PubMed ID: 24014830
21. Bergenin alleviates proliferative arterial diseases by modulating glucose metabolism in vascular smooth muscle cells. Song Y, Deng M, Qiu Y, Cui Y, Zhang B, Xin J, Feng L, Mu X, Cui J, Li H, Sun Y, Yi W. Phytomedicine; 2024 Jul; 129():155592. PubMed ID: 38608597 [Abstract] [Full Text] [Related]
25. MicroRNA-206 regulates vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Sun H, Cai S, Zhang M, Zhao J, Wei S, Luo Y, Meng X, Zhou X, Li Y, Zhang W. Cell Biol Int; 2017 Jul; 41(7):739-748. PubMed ID: 28328152 [Abstract] [Full Text] [Related]
26. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Li P, Liu Y, Yi B, Wang G, You X, Zhao X, Summer R, Qin Y, Sun J. Cardiovasc Res; 2013 Jul 01; 99(1):185-93. PubMed ID: 23554459 [Abstract] [Full Text] [Related]
31. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury. Yao Y, Hu Z, Ye J, Hu C, Song Q, Da X, Yu Y, Li H, Xu C, Chen Q, Wang QK. J Am Heart Assoc; 2017 Jun 25; 6(6):. PubMed ID: 28649088 [Abstract] [Full Text] [Related]
32. The A10 cell line: a model for neonatal, neointimal, or differentiated vascular smooth muscle cells? Rao RS, Miano JM, Olson EN, Seidel CL. Cardiovasc Res; 1997 Oct 25; 36(1):118-26. PubMed ID: 9415280 [Abstract] [Full Text] [Related]
33. MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1. Kim MH, Ham O, Lee SY, Choi E, Lee CY, Park JH, Lee J, Seo HH, Seung M, Choi E, Min PK, Hwang KC. J Cell Biochem; 2014 Oct 25; 115(10):1752-61. PubMed ID: 24819721 [Abstract] [Full Text] [Related]
34. miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Merlet E, Atassi F, Motiani RK, Mougenot N, Jacquet A, Nadaud S, Capiod T, Trebak M, Lompré AM, Marchand A. Cardiovasc Res; 2013 Jun 01; 98(3):458-68. PubMed ID: 23447642 [Abstract] [Full Text] [Related]
35. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor. Choe N, Kwon JS, Kim YS, Eom GH, Ahn YK, Baik YH, Park HY, Kook H. Cell Signal; 2015 Jun 01; 27(6):1056-65. PubMed ID: 25683915 [Abstract] [Full Text] [Related]
36. PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Salabei JK, Cummins TD, Singh M, Jones SP, Bhatnagar A, Hill BG. Biochem J; 2013 May 01; 451(3):375-88. PubMed ID: 23421427 [Abstract] [Full Text] [Related]
38. MicroRNA‑199a‑5p regulates FOXC2 to control human vascular smooth muscle cell phenotypic switch. Cao Y, Cao Z, Wang W, Jie X, Li L. Mol Med Rep; 2021 Sep 01; 24(3):. PubMed ID: 34212977 [Abstract] [Full Text] [Related]
39. Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagy. Lin JJ, Chen R, Yang LY, Gong M, Du MY, Mu SQ, Jiang ZA, Li HH, Yang Y, Wang XH, Wang SF, Liu KX, Cao SH, Wang ZY, Zhao AQ, Yang SY, Li C, Sun SG. J Adv Res; 2024 Jun 01; 60():93-110. PubMed ID: 37499939 [Abstract] [Full Text] [Related]
40. MicroRNA-125b Affects Vascular Smooth Muscle Cell Function by Targeting Serum Response Factor. Chen Z, Wang M, Huang K, He Q, Li H, Chang G. Cell Physiol Biochem; 2018 Jun 01; 46(4):1566-1580. PubMed ID: 29689557 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]